Plain-English translation of NCT07840326 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase 2a clinical trial testing a medication called in people with progressive multiple sclerosis that is not currently active. Researchers want to understand whether this daily pill is safe to take and whether it might help reduce inflammation in the brain and spinal cord. The study will compare the medication at two different doses against a placebo (inactive pill) to see how well it works and what side effects it may cause.
Progressive MS can continue getting worse even when patients are not having active relapses, and current treatment options are limited. This trial is exploring whether this medication could help slow that progression by targeting inflammation in the nervous system.
You likely qualify if…
You likely don't qualify if…
You would take a daily oral pill — either the test medication at one of two dose levels or a placebo — over the course of the study. You would visit the research clinic for safety checks, blood work, and assessments to measure how the medication affects inflammation and disease progression. The study involves about 20 participants total, and researchers will carefully monitor your safety and how your body responds to the treatment.
AI-generated summary from trial data · Oct 4, 2026 · Not medical advice
United States